E. Holdener, R. Nissen-Meyer, G. Bonadonna, S. Jones, A. Howell, R. Rubens, H. Senn (1984)
Second malignant neoplasms in operable carcinoma of the breast.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 96
B. Hankey, R. Curtis, M. Naughton, J. Boice, J. Flannery (1983)
A retrospective cohort analysis of second breast cancer risk for primary breast cancer patients with an assessment of the effect of radiation therapy.Journal of the National Cancer Institute, 70 5
B. Fisher, J. Dignam, J. Bryant, N. Wolmark (2001)
Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial.Journal of the National Cancer Institute, 93 9
B. Fisher, Jong-Hyeon Jeong, S. Anderson, J. Bryant, E. Fisher, N. Wolmark (2002)
Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.The New England journal of medicine, 347 8
H. Ahsan, A. Neugut (1998)
Radiation Therapy for Breast Cancer and Increased Risk for Esophageal CarcinomaAnnals of Internal Medicine, 128
G. Chaplain, C. Milan, C. Sgro, P. Carli, C. Bonithon‐Kopp (2000)
Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 15
U. Veronesi, N. Cascinelli, L. Mariani, M. Greco, R. Saccozzi, A. Luini, Marisel Aguilar, E. Marubini (2002)
Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.The New England journal of medicine, 347 16
U. Magriples, F. Naftolin, P. Schwartz, M. Carcangiu (1993)
High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 11 3
Shapiro (1994)
Late effects of adjuvant therapy for breast cancerJNCI Monogr, 16
Hudis (2002)
Breast cancer and leukemiaAnn Surg Oncol, 9
Ellis (2001)
Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancerJ Clin Oncol, 19
B. Fisher, S. Anderson, E. Tan-chiu, N. Wolmark, D. Wickerham, Edwin Fisher, N. Dimitrov, J. Atkins, N. Abramson, S. Merajver, E. Romond, C. Kardinal, H. Shibata, R. Margolese, W. Farrar (2001)
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 19 4
P. Fumoleau, P. Kerbrat, P. Romestaing, P. Fargeot, A. Brémond, M. Namer, S. Schraub, M. Goudier, J. Mihura, A. Monnier, P. Clavère, D. Serin, P. Seffert, C. Pourny, T. Facchini, J. Jacquin, Jean-François Sztermer, J. Datchary, René Ramos, É. Luporsi (2003)
Randomized trial comparing six versus three cycles of epirubicin-based adjuvant chemotherapy in premenopausal, node-positive breast cancer patients: 10-year follow-up results of the French Adjuvant Study Group 01 trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 2
M. Ellis, A. Coop, Baljit Singh, L. Mauriac, Antonio Llombert-Cussac, F. Jänicke, W. Miller, D. Evans, M. Dugan, C. Brady, E. Quebe‐Fehling, M. Borgs (2001)
Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 19 18
Chaplain (2000)
Increased risk of acute leukemia after adjuvant chemotherapy for breast cancerJ Clin Oncol, 18
B. Fisher, S. Anderson, D. Wickerham, A. DeCillis, N. Dimitrov, E. Mamounas, N. Wolmark, R. Pugh, J. Atkins, F. Meyers, N. Abramson, J. Wolter, R. Bornstein, L. Levy, E. Romond, V. Caggiano, M. Grimaldi, P. Jochimsen, P. Deckers (1997)
Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 15 5
L. Bergman, M. Beelen, M. Gallee, H. Hollema, Jantien Benraadt, F. Leeuwen (2000)
Risk and prognosis of endometrial cancer after tamoxifen for breast cancerThe Lancet, 356
M. Clarke, R. Collins, C. Davies, J. Godwin, R. Gray, R. Peto (1998)
Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 352
J. Boice, E. Harvey, M. Blettner, M. Stovall, J. Flannery (1992)
Cancer in the contralateral breast after radiotherapy for breast cancer.The New England journal of medicine, 326 12
B. Fisher, J. Bryant, J. Dignam, D. Wickerham, E. Mamounas, Edwin Fisher, R. Margolese, L. Nesbitt, S. Paik, T. Pisansky, N. Wolmark (2002)
Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 20
R. Curtis, J. Boice, M. Stovall, J. Flannery, W. Moloney (1989)
Leukemia risk following radiotherapy for breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 7 1
G. Hayden, M. Kramer, R. Horwitz (1982)
The case-control study. A practical review for the clinician.JAMA, 247 3
Fisher (1994)
Endometrial cancer in tamoxifen-treated breast cancer patientsJ Natl Cancer Inst, 86
M. Baum (1998)
Polychemotherapy for early breast cancerThe Lancet, 352
H. Ahuja, C. Felix, P. Aplan (2000)
Potential role for DNA topoisomerase II poisons in the generation of t(11;20)(p15;q11) translocationsGenes, 29
M. Carcangiu (1994)
Re: Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.Journal of the National Cancer Institute, 86 16
A. Taghian, F. Vathaire, P. Terrier, M. Lê, A. Auquier, H. Mouriesse, E. Grimaud, D. Sarrazin, M. Tubiana (1991)
Long-term risk of sarcoma following radiation treatment for breast cancer.International journal of radiation oncology, biology, physics, 21 2
Lancet, 351
H. Stewart, A. Forrest, D. Everington, C. McDonald, J. Dewar, R. Hawkins, R. Prescott, W. George (1996)
Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group.British Journal of Cancer, 74
G. Leone, L. Mele, A. Pulsoni, F. Equitani, L. Pagano (1999)
The incidence of secondary leukemias.Haematologica, 84 10
M. Levine, V. Bramwell, K. Pritchard, B. Norris, L. Shepherd, H. Abu‐Zahra, B. Findlay, D. Warr, D. Bowman, J. Myles, A. Arnold, T. Vandenberg, R. Mackenzie, J. Robert, J. Ottaway, M. Burnell, C. Williams, D. Tu (1998)
Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16 8
Diamandidou (1996)
Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapyJ Clin Oncol, 14
M. Citron, D. Berry, C. Cirrincione, C. Hudis, E. Winer, W. Gradishar, N. Davidson, S. Martino, R. Livingston, J. Ingle, E. Perez, J. Carpenter, D. Hurd, J. Holland, Barbara Smith, C. Sartor, Eleanor Leung, J. Abrams, R. Schilsky, H. Muss, L. Norton (2003)
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 8
Fisher (1998)
Lumpectomy and radiation therapy for the treatment of intraductal breast cancerJ Clin Oncol, 16
T. Fornander, A. Hellström, B. Moberger (1993)
Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer.Journal of the National Cancer Institute, 85 22
B. Fraass, P. Roberson, A. Lichter (1985)
Dose to the contralateral breast due to primary breast irradiation.International journal of radiation oncology, biology, physics, 11 3
E. Diamandidou, A. Buzdar, T. Smith, D. Frye, M. Witjaksono, G. Hortobagyi (1996)
Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 14 10
A. Rubagotti, A. Perrotta, C. Casella, F. Boccardo (1996)
Risk of new primaries after chemotherapy and/or tamoxifen treatment for early breast cancer.Annals of oncology : official journal of the European Society for Medical Oncology, 7 3
Fornander (1993)
Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancerJ Natl Cancer Inst, 85
I. Henderson, D. Berry, G. Demetri, C. Cirrincione, L. Goldstein, S. Martino, J. Ingle, M. Cooper, D. Hayes, K. Tkaczuk, G. Fleming, J. Holland, D. Duggan, J. Carpenter, E. Iii, R. Schilsky, W. Wood, H. Muss, L. Norton, C. Henderson (2003)
Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 6
Fisher (1999)
Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancerJ Clin Oncol, 17
Mouridsen (2001)
Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancerJ Clin Oncol, 19
R. Chlebowski, N. Col, E. Winer, D. Collyar, S. Cummings, V. Vogel, H. Burstein, A. Eisen, I. Lipkus, D. Pfister (2002)
American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 15
C. Rubino, F. Vathaire, I. Diallo, A. Shamsaldin, M. Lê (2000)
Increased risk of second cancers following breast cancer: Role of the initial treatmentBreast Cancer Research and Treatment, 61
Lancer, 359
Lancet, 355
Morrow (2001)
Local management of invasive cancer
S. Galper, R. Gelman, A. Recht, B. Silver, A. Kohli, J. Wong, T. Buren, E. Baldini, J. Harris (2002)
Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.International journal of radiation oncology, biology, physics, 52 2
B. Fowble, A. Hanlon, G. Freedman, N. Nicolaou, P. Anderson (2001)
Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk.International journal of radiation oncology, biology, physics, 51 3
B. Fisher, J. Costantino, C. Redmond, Edwin Fisher, R. Margolese, N. Dimitrov, N. Wolmark, D. Wickerham, M. Deutsch, L. Ore, E. Mamounas, W. Poller, M. Kavanah (1993)
Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer.The New England journal of medicine, 328 22
R. Curtis, J. Boice, M. Stovall, L. Bernstein, R. Greenberg, J. Flannery, A. Schwartz, P. Weyer, W. Moloney, R. Hoover (1992)
Risk of leukemia after chemotherapy and radiation treatment for breast cancer.The New England journal of medicine, 326 26
Alfred Neugut, Weinberg, H. Ahsan, J. Rescigno (1999)
Carcinogenic effects of radiotherapy for breast cancer.Oncology, 13 9
L. Zablotska, A. Neugut (2003)
Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinomaCancer, 97
B. Fisher, J. Dignam, N. Wolmark, D. Wickerham, E. Fisher, E. Mamounas, Roy Smith, M. Begovic, N. Dimitrov, R. Margolese, C. Kardinal, M. Kavanah, L. Fehrenbacher, R. Oishi (1999)
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trialThe Lancet, 353
J. Vaidya, Mohammed Keshtgar, Michael Baum (2000)
Diseases of the breastBritish Journal of Cancer, 83
Roy Smith, J. Bryant, A. DeCillis, S. Anderson (2003)
Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 7
M. Vijver, Yudong He, L. Veer, H. Dai, A. Hart, D. Voskuil, G. Schreiber, J. Peterse, C. Roberts, M. Marton, M. Parrish, D. Atsma, A. Witteveen, A. Glas, L. Delahaye, Tony Velde, H. Bartelink, S. Rodenhuis, E. Rutgers, S. Friend, René Bernards (2002)
A gene-expression signature as a predictor of survival in breast cancer.The New England journal of medicine, 347 25
J. Harris, Patricia Halpin-Murphy, M. Mcneese, N. Mendenhall, M. Morrow, N. Robert (1999)
Consensus Statement on postmastectomy radiation therapy.International journal of radiation oncology, biology, physics, 44 5
Winer (2002)
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancerJ Clin Oncol, 20
B. Fisher, H. Rockette, E. Fisher, D. Wickerham, C. Redmond, A. Brown (1985)
Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 3 12
J. Nabholtz, A. Buzdar, M. Pollak, W. Harwin, G. Burton, A. Mangalik, M. Steinberg, A. Webster, M. Voneuler (2000)
Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 22
Rubino (2000)
Increased risk of second cancers following breast cancerBreast Cancer Res Treat, 61
Tewart, Nderson, Ohn, RYANt, Ichard, M. G., Argolese, Elvin, Eutsch, Dwin, F. R., Isher, Ong, H, Yeon, Eong, Orman, Olmark (2002)
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.The New England Journal of Medicine, 347
M. Prochazka, F. Granath, A. Ekbom, P. Shields, P. Hall (2002)
Lung cancer risks in women with previous breast cancer.European journal of cancer, 38 11
Marchal (1999)
Nine breast angiosarcomas after conservative treatment for breast carcinomaInt J Radiat Oncol Biol Phys, 44
R. Cersosimo (2003)
Tamoxifen for Prevention of Breast CancerAnnals of Pharmacotherapy, 37
C. Felix (2001)
Leukemias related to treatment with DNA topoisomerase II inhibitors.Medical and pediatric oncology, 36 5
E. Obedian, D. Fischer, B. Haffty (2000)
Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 12
Fisher (1997)
Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancerJ Clin Oncol, 15
Inskip (1994)
Lung cancer risk and radiation dose among women treated for breast cancerJ Natl Cancer Inst, 86
C. Shapiro, P. Mauch (1992)
Radiation-associated breast cancer after Hodgkin's disease: risks and screening in perspective.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 10 11
Cummings (1999)
The effect of raloxifene on risk of breast cancer in postmenopausal womenJAMA, 281
Storm (1992)
Adjuvant radiotherapy and risk of contralateral breast cancerJ Natl Cancer Inst, 84
Nabholtz (2000)
Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal womenJ Clin Oncol, 18
J. Wils, J. Bliss, M. Marty, G. Coombes, C. Fontaine, F. Morvan, T. Olmos, F. Pérez-López, P. Vassilopoulos, E. Woods, R. Coombes (1999)
Epirubicin plus tamoxifen versus tamoxifen alone in node-positive postmenopausal patients with breast cancer: A randomized trial of the International Collaborative Cancer Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 17 7
A. Neugut, T. Murray, Jason Santos, H. Amols, M. Hayes, J. Flannery, Eliezer Robinson (1994)
Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokersCancer, 73
Michele Herring, A. Buzdar, T. Smith, G. Hortobagyi, G. Blumenschein (1986)
Second Neoplasms After Adjuvant Chemotherapy for Operable Breast CancerAmerican Journal of Clinical Oncology, 9
Timothy Whelan, J. Julian, J. Wright, A. Jadad, M. Levine (2000)
Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 6
B. Fisher, J. Dignam, N. Wolmark, E. Mamounas, J. Costantino, W. Poller, E. Fisher, D. Wickerham, M. Deutsch, R. Margolese, N. Dimitrov, M. Kavanah (1998)
Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16 2
B. Fisher, J. Costantino, C. Redmond, R. Poisson, D. Bowman, J. Couture, N. Dimitrov, N. Wolmark, D. Wickerham, Edwin Fisher, R. Margolese, A. Robidoux, H. Shibata, J. Terz, A. Paterson, M. Feldman, W. Farrar, James Evans, H. Lickley, Mary Ketner (1989)
A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors.The New England journal of medicine, 320 8
M. Tallman, R. Gray, J. Bennett, D. Variakojis, N. Robert, W. Wood, J. Rowe, P. Wiernik (1995)
Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 13 7
P. Inskip, M. Stovall, J. Flannery, J. Flannery (1994)
Lung cancer risk and radiation dose among women treated for breast cancer.Journal of the National Cancer Institute, 86 13
C. Shapiro, A. Recht (2001)
Side effects of adjuvant treatment of breast cancer.The New England journal of medicine, 344 26
B. Fisher, S. Anderson, A. DeCillis, N. Dimitrov, J. Atkins, L. Fehrenbacher, P. Henry, E. Romond, K. Lanier, E. Davila, C. Kardinal, L. Laufman, H. Pierce, N. Abramson, A. Keller, J. Hamm, D. Wickerham, M. Begovic, E. Tan-chiu, W. Tian, N. Wolmark (1999)
Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-25.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 17 11
T. Delozier, M. Spielmann, J. Macé-Lesec’h, M. Janvier, C. Hill, B. Asselain, J. Julien, B. Weber, L. Mauriac, J. Petit, P. Kerbrat, J. Malhaire, P. Vennin, B. Leduc, Moïse the (2000)
Tamoxifen adjuvant treatment duration in early breast cancer: initial results of a randomized study comparing short-term treatment with long-term treatment. Fédération Nationale des Centres de Lutte Contre le Cancer Breast Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 20
C. Rubino, F. Vathaire, I. Diallo, A. Shamsaldin, E. Grimaud, M. Labbé, G. Contesso, M. Lê (2002)
Radiation Dose, Chemotherapy and Risk of Lung Cancer After Breast Cancer TreatmentBreast Cancer Research and Treatment, 75
B. Fisher, J. Costantino, D. Wickerham, C. Redmond, M. Kavanah, W. Cronin, V. Vogel, A. Robidoux, N. Dimitrov, J. Atkins, M. Daly, S. Wieand, E. Tan-chiu, L. Ford, N. Wolmark (1999)
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.Journal of the National Cancer Institute, 90 18
L. Strobbe, H. Peterse, H. Tinteren, A. Wijnmaalen, E. Rutgers (2004)
Angiosarcoma of the breast after conservation therapy for invasive cancer, the incidence and outcome. An unforeseen sequelaBreast Cancer Research and Treatment, 47
A. Neugut, Won Lee, T. Murray, E. Robinson, Kevin Karwoski, G. Kutcher (1993)
Lung cancer after radiation therapy for breast cancerCancer, 71
C. Marchal, B. Weber, B. Lafontan, M. Resbeut, H. Mignotte, P. chatelard, B. Cutuli, M. Reme-saumon, Agnès Broussier-leroux, G. Chaplain, F. Lesaunier, J. Dilhuydy, J. Lagrange (1999)
Nine breast angiosarcomas after conservative treatment for breast carcinoma: a survey from French comprehensive Cancer Centers.International journal of radiation oncology, biology, physics, 44 1
Fowble (2001)
Second cancers after conservative surgery and radiation for stages I-II breast cancerInt J Radiat Oncol Biol Phys, 51
G. Leone, M. Voso, S. Sica, R. Morosetti, L. Pagano (2001)
Therapy Related Leukemias: Susceptibility, Prevention and TreatmentLeukemia & Lymphoma, 41
B. Riggs, L. Hartmann (2003)
Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.The New England journal of medicine, 348 7
R. Arriagada, L. Rutqvist (1991)
Adjuvant chemotherapy in early breast cancer and incidence of new primary malignanciesThe Lancet, 338
Obedian (2000)
Second malignancies after treatment of early-stage breast cancerJ Clin Oncol, 18
H. Mouridsen, M. Gershanovich, Yan Sun, R. Pérez-Carrión, C. Boni, A. Monnier, J. Apffelstaedt, Robert Smith, H. Sleeboom, F. Jänicke, A. Płużańska, M. Dank, D. Becquart, P. Bapsy, E. Salminen, R. Snyder, M. Lassus, J. Verbeek, Beatrix Staffler, H. Chaudri-Ross, M. Dugan (2001)
Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 19 10
M. Clarke, R. Collins, C. Davies, J. Godwin, R. Gray, R. Peto (2000)
Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 355
Fisher (1985)
Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiationJ Clin Oncol, 3
Hankey (1983)
A retrospective cohort analysis of second breast cancer risk for primary breast cancer patients with an assessment of the effect of radiation therapyJ Natl Cancer Inst, 70
Fisher (2001)
Five versus more than five years of tamoxifen for lymph node-negative breast cancerJ Natl Cancer Inst, 93
Delozier (2000)
Tamoxifen adjuvant treatment duration in early breast cancer: Initial results of a randomized study comparing short-term treatment with long-term treatmentJ Clin Oncol, 18
M. Baum, A. Budzar, J. Cuzick, J. Forbes, J. Houghton, J. Klijn, T. Sahmoud (2002)
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trialThe Lancet, 359
Steven Cummings, Stephen Eckert, Kathryn Krueger, Deborah Grady, Trevor Powles, Jane Cauley, Larry Norton, Thomas Nickelsen, Nina Bjarnason, Monica Morrow, Marc Lippman, Dennis Black, J. Glusman, Alberto Costa, V. Jordan (1999)
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.JAMA, 281 23
Shapiro (1992)
Radiation-associated breast cancer after Hodgkin?s diseaseJ Clin Oncol, 10
H. Storm, M. Andersson, J. Boice, M. Blettner, M. Stovall, H. Mouridsen, P. Dombernowsky, C. Rose, A. Jacobsen, M. Pedersen (1992)
Adjuvant radiotherapy and risk of contralateral breast cancer.Journal of the National Cancer Institute, 84 16
E. Winer, C. Hudis, H. Burstein, A. Wolff, K. Pritchard, J. Ingle, R. Chlebowski, R. Gelber, S. Edge, J. Gralow, M. Cobleigh, E. Mamounas, L. Goldstein, T. Whelan, T. Powles, J. Bryant, Cheryl Perkins, J. Perotti, S. Braun, A. Langer, G. Browman, M. Somerfield (2002)
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 3
P. Valagussa, A. Moliterni, M. Terenziani, M. Zambetti, G. Bonadonna (1994)
Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer.Annals of oncology : official journal of the European Society for Medical Oncology, 5 9
Levine (1998)
Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosophamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancerJ Clin Oncol, 16
Fisher (1998)
Tamoxifen for prevention of breast cancerJ Natl Cancer Inst, 90
Wils (1999)
Epirubicin plus tamoxifen versus tamoxifen alone in node-positive postmenopausal patients with breast cancerJ Clin Oncol, 17
O. Abe, R. Abe, K. Enomoto, K. Kikuchi, H. Koyama, Y. Nomura, K. Sakai, K. Sugimachi, T. Tominaga, J. Uchino, M. Yoshida, A. Velde, J. Dongen, J. Vermorken, G. Giokas, B. Lissaios, V. Harvey, TM Holdaway, R. Kay, B. Mason, A. Coates, J. Forbes, C. Focan, J. Lobelle, U. Peek, G. Oates, J. Powell, M. Durand, L. Mauriac, S. Bartholomeus, M. Piccart, R. Gelman, J. Harris, Claire Shapiro, A. Hancock, M. Masood, D. Parker, J. Price, S. Jackson, J. Ragaz, T. Delozier, J. Macé-Lesec’h, J. Haybittle, C. Cirrincione, I. Henderson, A. Korzun, R. Weiss, W. Wood, M. Baum, J. Houghton, D. Riley, D. Dent, C. Gudgeon, A. Hacking, K. Horgan, L. Hughes, H. Stewart, NH Gordon, H. Davis, P. Romestaing, Y. Lehingue, J. Owen, P. Meier, A. Howell, G. Ribeiro, R. Swindell, J. Albano, Cf Oliveira, H. Gervásio, J. Gordilho, B. Carstensen, T. Palshof, H. Johansen, S. Korzeniowski, J. Skołyszewski, S. Portnoj, K. Andersen, C. Axelsson, M. Blichert‐Toft, H. Mouridsen, M. Overgaard, C. Rose, N. Corcoran, H. Trampisch, R. Comis, N. Davidson, R. Gray, N. Robert, D. Tormey, W. Wood, J. Rossbach, L. Bijnens, C. Velde, M. Cunningham, G. Bastert, H. Rauschecker, R. Sauer, W. Sauerbrei, A. Schauer, M. Schumacher, A. Schryver, M. Belfiglio, E. Mari, A. Nicolucci, N. Scorpiglione, H. Yosef, C. McArdle, D. Smith, P. Lara, F. Boccardo, A. Rubagotti, A. Erazo, J. Medina, M. Izuo, Y. Morishita, A. Bentley, Z. Doran, I. Fentiman, J. Hayward, R. Rubens, M. Kaufmann, W. Jonat, D. Fournier, G. Fountzilas, P. Klefstrom, C. Blomqvist, J. Cuzick, R. Margreiter, M. Castiglione, F. Cavalli, J. Collins, J. Forbes, R. Gelber, A. Goldhirsch, J. Lindtner, K. Price, C. Rudenstam, H. Senn, J. Bliss, R. Coombes, M. Marty, R. Borovik, G. Brufman, H. Hayat, Elise Robinson, N. Wigler, F. Pannuti, S. Takashima, T. Yasutomi, H. Sonoo, J. Yamashita, M. Ogawa, P. Hupperets, J. Bonte, I. Tengrup, L. Tennvall-Nittby, P. Martin, S. Romain, D. Ahmann, D. Schaid, A. Buzdar, T. Smith, T. Hakes, L. Norton, R. Wittes, R. Huerta, MG Sainz, G. Bonadonna, M. Vecchio, P. Valagussa, U. Veronesi, JB Dubois, A. Bianco, M. Lippman, L. Pierce, R. Simon, S. Steinberg, J. Myles, J. Pater, K. Pritchard, S. Anderson, A. Brown, J. Bryant, J. Costantino, J. Dignam, B. Fisher, C. Redmond, S. Wieand, N. Wolmark, I. Jackson, M. Palmer, J. Ingle, V. Suman, N. Bengtsson, L. Larsson, J. Lythgoe, M. Kissin, E. Hannisdal, J. Varhaug, R. Nissen-Meyer, R. Blamey, A. Mitchell, J. Robertson, Y. Nakamura, G. Máthé, J. Misset, H. Abu‐Zahra, E. Clarke, J. McLaughlin, R. Clark, M. Levine, K. Morimoto, K. Sawa, Y. Takatsuka, S. Gundersen, M. Hauer-Jensen, H. Høst, E. Crossley, A. Harris, C. Baker, A. Beighton, M. Clarke, R. Collins, C. Davies, T. Elphinstone, V. Evans, J. Godwin, E. Greaves, C. Harwood, A. Headon, C. Hicks, D. Jackson, Spencer James, E. Lau, P. Mcgale, G. Mead, H. Monaghan, S. Mozley, A. Naughten, R. Peto, A. Tooth, K. Wheatley, P. Rambert, B. Asselain, R. Salmon, J. Vilcoq, R. Arriagada, C. Hill, A. Laplanche, M. Lê, M. Spielmann, G. Cocconi, B. Blasio, R. Catalano, R. Creech, J. Brockschmidt, M. Cooper, O. Andrysek, J. Barkmanova, C. Falkson, M. Abraham, J. Klijn, A. Treurniet‐Donker, W. Putten, D. Easton, T. Powles, J. Gazet, V. Semiglazov, A. Businico, S. Sardinia, N. Deshpande, L. Martino, P. Douglas, A. Lindtner, G. Notter, A. Bryant, G. Ewing, J. Krushen-Kosloski, A. Forrest, W. Jack, C. McDonald, T. Möller, S. Rydén, J. Carstensen, T. Hatschek, M. Söderberg, J. Carpenter, K. Albain, J. Crowley, S. Green, S. Martino, C. Osborne, P. Ravdin, L. Rutqvist, A. Wallgren, L. Holm, B. Thürlimann, H. Brenner, A. Hercbergs, M. Yoshimoto, G. Deboer, A. Paterson, J. Meakin, T. Panzarella, A. Naja, J. Bahi, M. Reid, M. Spittle, F. Senanayake, R. Love, D. Mets, J. Bergh, L. Holmberg, P. Sevelda, C. Zielinsky, M. Gnant, R. Jakesz, R. Buchanan, G. Royle, J. Dunn, W. Gillespie, K. Kelly, J. Morrison, A. Litton, R. Chlebowski, W. Bezwoda, H. Caffier (1998)
Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 351
Fisher (2001)
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancerJ Clin Oncol, 19
J. Yap, P. Chuba, Ron Thomas, A. Aref, D. Lucas, R. Severson, M. Hamre (2002)
Sarcoma as a second malignancy after treatment for breast cancer.International journal of radiation oncology, biology, physics, 52 5
Smith (2003)
Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancerJ Clin Oncol, 21
C. Shapiro, A. Recht (1994)
Late effects of adjuvant therapy for breast cancer.Journal of the National Cancer Institute. Monographs, 16
Seminars in Oncology – Pubmed
Published: Jan 8, 2004
Access the full text.
Sign up today, get DeepDyve free for 14 days.